US20020045773A1 - Process for the preparation of stanol esters - Google Patents
Process for the preparation of stanol esters Download PDFInfo
- Publication number
- US20020045773A1 US20020045773A1 US09/367,836 US36783699A US2002045773A1 US 20020045773 A1 US20020045773 A1 US 20020045773A1 US 36783699 A US36783699 A US 36783699A US 2002045773 A1 US2002045773 A1 US 2002045773A1
- Authority
- US
- United States
- Prior art keywords
- transesterification
- hydrogenation
- stanol
- catalyst
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Definitions
- the present invention relates to a process for the preparation of stanol esters, and in particular to a process wherein stanol esters are prepared by hydrogenating at least one sterol in a solvent and at an elevated temperature in the presence of a hydrogenation catalyst to the corresponding stanol or stanol blend, by removing the hydrogenation catalyst from the obtained reaction solution, by transesterifing the stanol or the stanol blend with a lower alkyl ester at an elevated temperature and in the presence of a transesterification catalyst, and by finally purifying the stanol ester or stanol ester blend thus obtained.
- Sterols are compounds commonly present in plants and animals, although in small concentrations.
- the sterol compound most commonly present in animals is cholesterol.
- the sterol material present in plants is usually composed of several sterol structures which resemble each other structurally. The most common of the latter are ⁇ -sitosterol, campesterol and stigmasterol.
- ⁇ -sitosterol campesterol
- stigmasterol Depending on the plant species, there may also be present numerous other compounds resembling the above-mentioned sterols, for example brassicasterol in rape, ⁇ -sitosterol and betulinol in birch, methylene cycloartanol and cycloartenol, avenasterols, etc.
- the sterols of wood material also include saturated sterol compounds wherein particularly the double bond between carbon atoms 5 and 6 of the sterol structure is hydrogenated to a saturated carbon-carbon bond. These compounds are called stanols.
- Hydrogenation of sterols is described e.g. in Organic Preparations and Procedures 1 (2) (1969) 107-109 (Augustine, R. L. and Reardon Jr. E. J.: The Palladium catalyzed hydrogenation of cholesterol) and Atherosclerosis 24 (1975) 301-309 (Sugano, M. et al.: Lipid-lowering activity of phytosterols in rats).
- Cholesterol is a compound indispensable for human subjects, as for other vertebrates, for example as an ingredient of cell structures. In high concentrations, however, cholesterol is detrimental, since it accumulates on the walls of blood vessels and thereby increases the risk of cardiovascular diseases.
- the method conventionally used for preparing the compounds concerned, so-called stanol esters is a procedure according to which the sterol is first hydrogenated catalytically in a hydrogenation solvent.
- the hydrogenated sterol (stanol) is crystallized and subsequently isolated by filtration from the reaction mixture, and is thereafter transferred to a transesterification process, in which the transesterification reagent is typically a vegetable oil methyl ester.
- the object of the present invention is thus to provide a more advanced method than previously for the preparation of fat-soluble stanol esters, simplifying the preparation process of stanol esters and thereby lowering the investment costs of the plant for the preparation of stanol esters and, owing to the almost quantitative yield, at the same time maximizing the production of a stanol ester end product of a sufficiently high quality.
- the present invention thus provides a stanol ester preparation method of the type mentioned in the preamble, the principal characteristics of the process being stated in the accompanying claims.
- the invention is based on the idea that the investment costs of a plant for the preparation of stanol esters can be lowered substantially by omitting the crystallization of the stanol intermediate and the filtration of the crystalline stanol intermediate from the reaction mixture, when the hydrogenation solvent is left in the reaction solution from which the hydrogenation catalyst has been removed.
- the hydrogenation solvent is removed from the reaction mixture only after adding the transesterification reagent and the transesterification solvent, if any, to the reaction mixture.
- the hydrogenation solvent used is one which serves as the solvent and reagent also in the transesterification.
- a fatty acid methyl ester of vegetable oil origin is used as the transesterification reagent and possibly as the hydrogenation solvent. It is especially advantageous to use a hydrogenation solvent having a lower boiling point than the transesterification reagent, in which case the hydrogenation solvent can be removed by distillation from a reaction solution to which the transesterification reagent is added or has been added. In this manner, the passing of saturated fatty acids to the stanol ester end product is avoided.
- the hydrogenation solvent used is preferably a methyl ester of coconut fatty acids or palm kernel oil fatty acids, whereas the transesterification reagent is a methyl ester of rapeseed oil fatty acids.
- the source of the fatty acid or fatty acid blend alcohol ester used as the transesterification reagent may be the fatty acids of any fat, oil, or blends thereof.
- Stanol esters can indeed be prepared according to the invention, without the crystallization and isolation of stanols, also by using conventional hydrogenation solvents instead of fatty acid methyl esters.
- the suitable solvents include alcohols, hydrocarbons and ethers, such as tetrahydrofuran. It is particularly advantageous to use a high boiling aromate-free and thus inert aliphatic hydrocarbon as the hydrogenation solvent, since it does not react with the transesterification reagent in the transesterification step. This alternative is preferable when it is desired to prevent the incorporation of saturated fatty acids into the stanol ester product.
- the fatty acid methyl ester used in the transesterification is added to the post-hydrogenation reaction mixture from which the hydrogenation catalyst has been removed, and thereafter the hydrogenation solvent is removed by distillation before the actual transesterification.
- the use of fatty acid methyl esters can, however, be justified, since they have a higher flash point than have conventional solvents, such as n-propanol, which means improved fire safety.
- the hydrogenation catalyst used is preferably a noble metal catalyst, such as palladium on carbon or on an organic polymer compound.
- the hydrogenation is preferably carried out at a temperature of at most about 120° C., but the hydrogen pressure may vary in a wide range.
- the amount of the hydrogenation catalyst used in the reaction may vary, but may preferably be used in an amount of 0,1-2% active ingredient of the weight of the sterol to be hydrogenated.
- the hydrogenation catalyst is removed by filtration from the hot reaction mixture.
- the filtration of the hydrogenation catalyst is problem-free and does not require high investments.
- the transesterification catalyst used is preferably an alkali metal alcoholate, such as sodium methylate or sodium ethylate.
- the amount of transesterification catalyst is preferably 0.1-1% of the weight of the reaction solution.
- the transesterification is preferably carried out at 100-130° C. and by using a stoichiometric excess of the transesterification reagent, for example a double excess, relative to the stanol or the stanol blend.
- the starting substance used may be any sterol or sterol blend obtainable from plants, and in principle also animal sterols, for example cholesterol or lanosterol.
- a sterol blend is hydrogenated which contains mainly sitosterol and additionally campesterol and possibly stigmasterol.
- a sterol blend based on tall oil or vegetable oil is hydrogenated.
- dehydrogenation products of tocopherols and sterols, long-chained hydrocarbons, and fatty alcohols) formed in the reaction and brought in by the raw materials were rather high, their removal by the method according to the invention is possible by using, for example, steam distillation and adsorption, known per se. In addition to these purification procedures, for example, thin film evaporation can also be used.
- the hydrogenation it is preferable to use as catalyst a noble metal catalyst such as palladium, platinum or ruthenium. Also possible is, for example, Raney nickel, cobalt, or copper chromite compounds.
- the catalyst support may be, for example, carbon, alumina, silica gel, or an organic polymeric compound.
- the hydrogenation is most preferably carried out at a temperature below about 120° C.
- the pressure in the reaction mixture may vary widely.
- the catalyst concentration may also vary within a wide range.
- the hydrogenation catalyst is removed from the hot reaction mixture by filtration.
- the removal of a portion of the hydrogenation solvent (methyl ester or some other solyent) is desired before the transesterification, it must be done in the subsequent step. This is done by adding the fatty acid methyl ester to be used in the transesterification to the hydrogenation reaction mixture before the distillation or simultaneously with the distillation.
- the conditions used in the distillation of the solvent are, of course, dependent on the physical properties of the solvent used. It is, however, a marginal condition that the boiling point of the hydrogenation solvent must deviate sufficiently (must be lower) from the boiling point of the fatty acid ester serving as the reagent, in order for fractional removal of the hydrogenation solvent to be possible.
- the next step in the preparation of stanol ester is the transesterification of the stanol with the fatty acid ester contained in the reaction solution.
- the esterification reaction per se may take place under the effect of any reagent catalyzing transesterification (examples include inorganic acids, toluene sulfonic acids, organostannates or alkaline catalysts).
- transesterification alkali metal alcoholates for example, sodium methylate or sodium ethylate
- transesterification catalysts well known per se from the literature in the field.
- the catalyst concentration and the other reaction conditions required vary largely as a function of the type of catalyst used.
- the catalyst in an amount of approx. 0.1-1% of the amount of the reaction mixture.
- the temperature being approx. 100-130° C., the reaction occurs completely within approx. 60-180 min when an approx. double stoichiometric excess of the fatty acid methyl ester relative to the stanol amount is used in the transesterification.
- the impurities formed in the reaction and brought in with the raw material can be removed by means of water washes and by water vapor distillation and additionally, when necessary, by causing the impurities to be absorbed into a suitable absorbent material (examples include activated carbon and/or bleaching earth).
- Steam distillation is a necessary purification step also for the removal of any reagent excess. Suitable conditions in the steam distillation step, when the reagent is the methyl ester of rapeseed fatty acids, are: temperature 180-230° C., pressure 1-10 mbar, and the amount of steam to be fed approx. 2-10% of the total amount of the reaction mixture.
- the hydrogenation catalyst was removed by distillation from the hot reaction mixture. Thereafter 360 g of rapeseed oil fatty acid methyl ester was directed to the reaction mixture, and the coconut methyl ester which had served as a solvent was removed by distillation at a temperature of 140° C. and a pressure of 8 mbar. Thereafter 3 g of sodium methylate was added as an esterification catalyst, and the esterification reaction was allowed to occur at 120° C. for 1.5 h at a pressure of 5 mbar. The ester product was washed twice with water, and the excess methyl ester reagent and impurities were steam distilled at a temperature of 200° C. and a pressure of 3 mbar.
- the product was filtered while hot through bleaching earth and a layer of activated carbon.
- the stanol ester product contained free fatty acids 0.02%, fatty acid methyl esters 0.3%, and unesterified sterol-derived compounds 0.8%.
- the melting point of the stanol ester was 36-39° C. according to DSC determination.
- the hydrogenation catalyst was removed from the hot reaction mixture by filtration.
- the stanol ester product contained free fatty acids 0.025%, fatty acid methyl esters 0.3%, and unesterified sterol-derived products 0.6%.
- the melting point of the stanol ester was 93-97° C. according to DSC determination.
- rapeseed oil methyl ester was used as the hydrogenation solvent and at the same time as the esterification reagent instead of coconut fat methyl ester.
- the reaction and the purification steps were carried out as in Example 2 (however, the temperature and pressure were 200-205° C./3-4 mbar throughout the steam distillation).
- the product obtained was a wax having a melting range of 98-104° C.
- the hydrogenation solvent used was coconut fatty acid methyl ester, which was partly removed by distillation and replaced with rapeseed oil methyl ester before the transesterification.
- 250 g of a sterol derived from vegetable oil was slurried into 650 g of coconut fatty acid methyl ester.
- a Pd/C catalyst was added in an amount of 0.2%, and the sterol was hydrogenated as in the preceding examples.
- the hydrogenation catalyst was removed from the hot reaction mixture by filtration. Thereafter, 300 g of rapeseed oil methyl ester was added to the reaction mixture, and 300 g of the saturated coconut fatty acid ester was distilled at a temperature of 140-150° C. and a pressure of 7-9 mbar.
- the mixture was transesterified and purified in the manner described in the preceding examples.
- the reaction product was a light yellow wax having a melting range of 69-74° C.
- Example 1 In the process according to Example 1, a high boiling (distillation range 180-210° C.) aliphatic hydrocarbon free of aromatic compounds was used as the hydrogenation solvent instead of coconut fatty acid ester. The reactions and purification processes were carried out substantially in the manner described in Example 1. The reaction product obtained was a wax corresponding to the product of Example of 1 and having a melting range of 37-40° C.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Fats And Perfumes (AREA)
- Compounds Of Unknown Constitution (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/234,138 US6855837B2 (en) | 1997-02-26 | 2002-09-05 | Process for the preparation of stanol esters |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI970802A FI107538B (sv) | 1997-02-26 | 1997-02-26 | Förfarande för framställning av stanolestrar |
FI970802 | 1997-02-26 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FI1998/000166 A-371-Of-International WO1998038206A1 (en) | 1997-02-26 | 1998-02-25 | Process for the preparation of stanol esters |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/234,138 Continuation US6855837B2 (en) | 1997-02-26 | 2002-09-05 | Process for the preparation of stanol esters |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020045773A1 true US20020045773A1 (en) | 2002-04-18 |
Family
ID=8548283
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/367,836 Abandoned US20020045773A1 (en) | 1997-02-26 | 1998-02-25 | Process for the preparation of stanol esters |
US10/234,138 Expired - Fee Related US6855837B2 (en) | 1997-02-26 | 2002-09-05 | Process for the preparation of stanol esters |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/234,138 Expired - Fee Related US6855837B2 (en) | 1997-02-26 | 2002-09-05 | Process for the preparation of stanol esters |
Country Status (10)
Country | Link |
---|---|
US (2) | US20020045773A1 (sv) |
EP (1) | EP0975656B1 (sv) |
JP (1) | JP4368949B2 (sv) |
AT (1) | ATE217320T1 (sv) |
AU (1) | AU6101798A (sv) |
CA (1) | CA2280081C (sv) |
DE (1) | DE69805295T2 (sv) |
FI (1) | FI107538B (sv) |
RU (1) | RU2178795C2 (sv) |
WO (1) | WO1998038206A1 (sv) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070148311A1 (en) * | 2005-12-22 | 2007-06-28 | Bunge Oils, Inc. | Phytosterol esterification product and method of make same |
US20090232916A1 (en) * | 2004-08-09 | 2009-09-17 | Avidor Shulman | Food products for diabetics |
US20100184734A1 (en) * | 2003-02-10 | 2010-07-22 | Enzymotec Ltd. | Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
US8772270B2 (en) | 2004-08-10 | 2014-07-08 | Enzymotec Ltd. | Treatment methods requiring phyto-ingredients |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1066313A1 (de) * | 1998-03-23 | 2001-01-10 | Cognis Deutschland GmbH | Verfahren zur herstellung von stanolen |
CA2267929A1 (en) * | 1999-04-06 | 2000-10-06 | B.C. Chemicals Ltd. | Preparation of saturated phytosterols |
WO2001029060A2 (en) * | 1999-10-21 | 2001-04-26 | The Board Of Regents For Oklahoma State University | Sterol esters of conjugated linoleic acids and process for their production |
JP3774110B2 (ja) | 2000-07-19 | 2006-05-10 | 花王株式会社 | 食用油脂及びその製造法 |
JP4212278B2 (ja) * | 2001-03-01 | 2009-01-21 | 日本たばこ産業株式会社 | 移植片拒絶反応抑制剤 |
GB2372990B (en) * | 2001-03-09 | 2003-01-22 | Diarmaid Joseph Long | A process for the manufacture of sterol esters |
US20070031571A1 (en) * | 2005-08-03 | 2007-02-08 | Peter Cremer North America, Lp | Phytosterol esters |
EP1815745A1 (en) | 2006-02-03 | 2007-08-08 | Friesland Brands B.V. | Cholesterol-lowering dairy products and methods for their preparation |
EP1991070A2 (de) * | 2006-03-08 | 2008-11-19 | Cognis IP Management GmbH | Sterolhaltige pulver |
DE102006041302A1 (de) * | 2006-03-08 | 2007-09-13 | Cognis Ip Management Gmbh | Sterolester mit kurzkettigen Fettsäuren |
WO2010010228A1 (en) * | 2008-07-25 | 2010-01-28 | Raisio Nutrition Ltd | Effective hydrogenation process |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5745199A (en) * | 1980-09-01 | 1982-03-13 | Nisshin Oil Mills Ltd:The | Esterification product and cosmetic or external use preparation containing the same |
WO1992019640A1 (en) | 1991-05-03 | 1992-11-12 | Raision Margariini Oy | A substance for lowering high cholesterol level in serum and a method for preparing the same |
EP0914329B1 (en) * | 1996-07-05 | 2003-05-21 | Unilever N.V. | Method of manufacturing an ester mixture |
FI107015B (sv) * | 1996-08-09 | 2001-05-31 | Raisio Benecol Oy | Komposition av växtstanolfettsyraestrar och dess användning samt livsmedel |
ES2272882T3 (es) | 1997-08-22 | 2007-05-01 | Unilever N.V. | Composciones que comprenden estanol. |
-
1997
- 1997-02-26 FI FI970802A patent/FI107538B/sv not_active IP Right Cessation
-
1998
- 1998-02-25 US US09/367,836 patent/US20020045773A1/en not_active Abandoned
- 1998-02-25 JP JP53734698A patent/JP4368949B2/ja not_active Expired - Fee Related
- 1998-02-25 WO PCT/FI1998/000166 patent/WO1998038206A1/en active IP Right Grant
- 1998-02-25 AU AU61017/98A patent/AU6101798A/en not_active Abandoned
- 1998-02-25 AT AT98905436T patent/ATE217320T1/de active
- 1998-02-25 EP EP98905436A patent/EP0975656B1/en not_active Expired - Lifetime
- 1998-02-25 RU RU99120095/04A patent/RU2178795C2/ru not_active IP Right Cessation
- 1998-02-25 DE DE69805295T patent/DE69805295T2/de not_active Expired - Lifetime
- 1998-02-25 CA CA002280081A patent/CA2280081C/en not_active Expired - Fee Related
-
2002
- 2002-09-05 US US10/234,138 patent/US6855837B2/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100184734A1 (en) * | 2003-02-10 | 2010-07-22 | Enzymotec Ltd. | Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
US8507466B2 (en) | 2003-02-10 | 2013-08-13 | Enzymotec Ltd. | Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
US20090232916A1 (en) * | 2004-08-09 | 2009-09-17 | Avidor Shulman | Food products for diabetics |
US8772270B2 (en) | 2004-08-10 | 2014-07-08 | Enzymotec Ltd. | Treatment methods requiring phyto-ingredients |
US20070148311A1 (en) * | 2005-12-22 | 2007-06-28 | Bunge Oils, Inc. | Phytosterol esterification product and method of make same |
US20090238942A1 (en) * | 2005-12-22 | 2009-09-24 | Bunge Oils, Inc. | Phytosterol esterification product and method of making same |
US8323721B2 (en) * | 2005-12-22 | 2012-12-04 | Bunge Oils, Inc. | Phytosterol esterification product and method of making same |
Also Published As
Publication number | Publication date |
---|---|
US6855837B2 (en) | 2005-02-15 |
ATE217320T1 (de) | 2002-05-15 |
FI107538B (sv) | 2001-08-31 |
JP2001516344A (ja) | 2001-09-25 |
CA2280081C (en) | 2007-12-18 |
FI970802A (sv) | 1998-08-27 |
EP0975656A1 (en) | 2000-02-02 |
FI970802A0 (sv) | 1997-02-26 |
US20030004361A1 (en) | 2003-01-02 |
WO1998038206A1 (en) | 1998-09-03 |
DE69805295T2 (de) | 2002-08-29 |
CA2280081A1 (en) | 1998-09-03 |
JP4368949B2 (ja) | 2009-11-18 |
AU6101798A (en) | 1998-09-18 |
DE69805295D1 (de) | 2002-06-13 |
EP0975656B1 (en) | 2002-05-08 |
RU2178795C2 (ru) | 2002-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0975656B1 (en) | Process for the preparation of stanol esters | |
CA2143441C (en) | Recovery of tocopherol and sterol | |
RU2259750C2 (ru) | Продукт на основе оливкового масла, способ приготовления продукта на основе оливкового масла (варианты) и смесь сложных эфиров | |
US7244856B2 (en) | Processes for recovering phytosterols via crystallization | |
RU99120095A (ru) | Способ получения станоловых эфиров | |
US7368583B2 (en) | Process for recovery of plant sterols from by-product of vegetable oil refining | |
US5117016A (en) | Method for obtaining a stigmasterol enriched product from deodorizer distillate | |
KR20000064616A (ko) | 불포화식물성화합물의수소화방법및사용된촉매의재생방법 | |
US6762312B1 (en) | Process for purification of phytosterol from fatty acids and their esters | |
US6979743B1 (en) | Processes for preparing phytosterols and substantially citrostadienol-free phytosterols prepared thereby | |
US7173144B1 (en) | Process for producing phytosterols by saponification in an alcohol/water solvent | |
US20010007036A1 (en) | Process for the production of stanols | |
US6673951B1 (en) | Process for catalytically hydrogenating phytosterols | |
EP2318426B1 (en) | Effective hydrogenation process | |
WO2000059921A1 (en) | Preparation of saturated phytosterols | |
JP2001131199A (ja) | 植物ステロールの製法 | |
KR20020039297A (ko) | 고순도 스테롤의 제조방법 | |
JP2001131197A (ja) | 植物ステロールの製法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: RAISIO BENECOL LTD., FINLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RAISIO GROUP PLC;REEL/FRAME:010253/0788 Effective date: 19980406 |
|
AS | Assignment |
Owner name: RAISIO BENECOL LTD., FINLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EKBLOM, JARI;REEL/FRAME:010391/0724 Effective date: 19990924 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |